Supreme Court Rejects Second Roundup Lawsuit Verdict Appeal By Bayer
Bayer had hoped a Roundup lawsuit verdict appeal to the Supreme Court would effectively end the litigation
Bayer had hoped a Roundup lawsuit verdict appeal to the Supreme Court would effectively end the litigation
A hearing for final approval of the settlement agreement for the Roundup class action lawsuit is slated for January 2023.
U.S. Supreme Court rejected an appeal Bayer hoped would end the ability for thousands of Roundup lawsuits to move forward over allegations that non-Hodgkin's lymphoma was caused by the weed killer
EPA failed to follow both the law and its own guidelines in determining whether glyphosate, the active ingredient in Roundup causes cancer, according to opinion.
Researchers found Roundup exposure, when combined with another chemical, led to lung inflammation in mice which was more pronounced in males than in females.
The U.S. Solicitor asked the Supreme Court not to consider a Roundup lawsuit appeal that stems from a $25 million award to a plaintiff diagnosed with non-Hodgkins lymphoma
A federal judge called for more clarity in notices sent to class participants, so they are aware the Roundup class settlement does not prevent them from bringing personal injury claims if diagnosed with non-Hodgkins lymphoma
Roundup litigation costs have made the Monsanto purchase a bad deal for shareholders and the company, the investors claim
Bayer claims the Roundup lymphoma verdict imposed excessive punitive damages and claims it is protected from liability by the EPA's decision that Roundup is safe.
Rat studies linked exposure to glyphosate in Roundup to gut microbiome disruptions and oxidative stress similar to those linked to some forms of cancer.